Management of Vitiligo with Homoeopathic medicines

Observational study to evaluate response to homoeopathic treatment in vitiligo

Status

Recruiting

Phases

Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/01/011611

Enrollment

270

Registered

2018-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vitiligo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Atleast 01 vitiligo skin lesion measuring at least 2x2cm in size. 2 Vitiligo patients with lesions of duration 03 months to 10 years.

Exclusion criteria

Exclusion criteria: •Use of topical/systemic treatment for vitiligo in past 08 weeks •Use of laser or light- based vitiligo treatments within the past 08 weeks •Treatment with immune-modulating oral medications in past 08 weeks. •Evidence of skin conditions (like Pityriasis versicolor, Pityriasis alba or post inflammatory hypopigmentation) other than vitiligo that would interfere with evaluations of the effect of study medication on vitiligo

Design outcomes

Primary

Measure	Time frame
1. Change in Vitiligo Area Scoring Index 2. Change in VETF (Vitiligo European Task Force). Timepoint: At Baseline and every month for 1 year.	—

Secondary

Measure	Time frame
â?¢Change in Quality of life measured using Dermatology Life Quality Index â?¢Change in depigmentation & pattern of repigmentation by digital photography. Timepoint: At Baseline and every month for 1 year.	—

Countries

India

Contacts

Public ContactDr Anil Khurana

Central Council for Research in Homoeopathy

ccrhindia@gmail.com01128525749

Outcome results